Evidence map›Paper›PMID 26504231›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

OVO-like 1 regulates progenitor cell fate in human trophoblast development.

Stephen J Renaud, Damayanti Chakraborty, Clifford W Mason, M A Karim Rumi, Jay L Vivian, Michael J Soares

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Trophoblast Fusion Deficiency in Placenta-Related Pregnancy Disorders.Advances in experimental medicine and biology · 2026
    Review
  5. Review
  6. BHLHE40 Cooperates with GATA2/3 to Control Human Syncytiotrophoblast Lineage Differentiation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Trophoblast Fusion in Hypertensive Disorders of Pregnancy and Preeclampsia.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Frontiers in cell and developmental biology · 2025
    Review
  13. Article
  14. Article
  15. NOTUM-mediated WNT silencing drives extravillous trophoblast cell lineage development.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Transcriptomic comparison of in vitro models of the human placenta.bioRxiv : the preprint server for biology · 2024
    Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Stephen J RenaudInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160; srenaud4@uwo.ca msoares@kumc.edu.
Damayanti ChakrabortyInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160;
Clifford W MasonInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS 66160.
M A Karim RumiInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160;
Jay L VivianInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160;
Michael J SoaresInstitute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160; Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS 66160 srenaud4@uwo.ca msoares@kumc.edu.
Institute for Reproductive Health · USUniversity of Kansas Medical Center · US

Funding

TROPHOBLAST DIFFERENTIATIONR01HD020676 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MICHAEL J SOARES · 1986 to 2026
$10.1M
Stem Cells and Epigenetics of Trophoblast Lineage DevelopmentP01HD079363 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WOLFE, MICHAEL W · 2014 to 2018
$5.7M
Role of OVO-like 1 in the regulation of human trophoblast differentiationR03HD079850 · NICHD · UNIVERSITY OF WESTERN ONTARIO · PI RENAUD, STEPHEN JAMES · 2014 to 2016
$109k
NICHD NIH HHS HD020676NICHD NIH HHS HD079363NICHD NIH HHS HD079850NICHD NIH HHS P01 HD079363NICHD NIH HHS R01 HD020676NICHD NIH HHS R03 HD079850
6 · The paper itself

Abstract

Epithelial barrier integrity is dependent on progenitor cells that either divide to replenish themselves or differentiate into a specialized epithelium. This paradigm exists in human placenta, where cytotrophoblast cells either propagate or undergo a unique differentiation program: fusion into an overlying syncytiotrophoblast. Syncytiotrophoblast is the primary barrier regulating the exchange of nutrients and gases between maternal and fetal blood and is the principal site for synthesizing hormones vital for human pregnancy. How trophoblast cells regulate their differentiation into a syncytium is not well understood. In this study, we show that the transcription factor OVO-like 1 (OVOL1), a homolog of Drosophila ovo, regulates the transition from progenitor to differentiated trophoblast cells. OVOL1 is expressed in human placenta and was robustly induced following stimulation of trophoblast differentiation. Disruption of OVOL1 abrogated cytotrophoblast fusion and inhibited the expression of a broad set of genes required for trophoblast cell fusion and hormonogenesis. OVOL1 was required to suppress genes that maintain cytotrophoblast cells in a progenitor state, including MYC, ID1, TP63, and ASCL2, and bound specifically to regions upstream of each of these genes. Our results reveal an important function of OVOL1 as a regulator of trophoblast progenitor cell fate during human trophoblast development.

Indexed as

Analysis of VarianceAnimalsBase SequenceBlotting, WesternCell DifferentiationChromatin ImmunoprecipitationDNA-Binding ProteinsFemaleFluorescent Antibody TechniqueGene Expression Regulation, DevelopmentalHumansImmunohistochemistryIn Situ HybridizationMiceMice, Inbred C57BLMicroarray AnalysisDNA-Binding ProteinsOVOL1 protein, humanRNA, Small InterferingTranscription Factorsdifferentiationepithelial barrierOVO-like 1placentatrophoblast

Identifiers

PMID26504231
PMCPMC4653227
OpenAlexW1795385610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.